Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
Rajmohamed Mohamed Asik, Natarajan Suganthy, Mohamed Asik Aarifa, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1126-1126
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Bartosz Twarowski, Mariola Herbet
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6518-6518
Open Access | Times Cited: 99
Modeling Alzheimer’s Disease in Caenorhabditis elegans
Javier Álvarez, Pilar Álvarez-Illera, Jaime Santo‐Domingo, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 288-288
Open Access | Times Cited: 48
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
Wenjun Cai, Tong Wu, Ning Chen
Biomolecules (2023) Vol. 13, Iss. 2, pp. 313-313
Open Access | Times Cited: 27
New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
Botond Penke, Mária Szűcs, Ferenc Bogár
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5383-5383
Open Access | Times Cited: 23
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Niraj Kumar Jha, Niraj Kumar Jha, Mohana Vamsi Nuli, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102224-102224
Closed Access | Times Cited: 14
Structure and function of therapeutic antibodies approved by the US FDA in 2023
William R. Strohl
Antibody Therapeutics (2024) Vol. 7, Iss. 2, pp. 132-156
Open Access | Times Cited: 8
Antioxidant and anti-Alzheimer's disease activities of 1,8-cineole and its cyclodextrin inclusion complex
Xin Tan, Rui Xu, А. А. Ли, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116784-116784
Open Access | Times Cited: 6
IL-17 A Exacerbated Neuroinflammatory and Neurodegenerative Biomarkers in Intranasal Amyloid-Beta Model of Alzheimer’s Disease
Avtar Singh Gautam, Shivam Kumar Pandey, Sneha Balki, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
TBK1-medicated DRP1 phosphorylation orchestrates mitochondrial dynamics and autophagy activation in osteoarthritis
Sunli Hu, Abdullah Al Mamun, Jian Shaw, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 3, pp. 610-621
Open Access | Times Cited: 21
Advancing Alzheimer’s Therapeutics: Exploring the Impact of Physical Exercise in Animal Models and Patients
Jesús Andrade-Guerrero, Paola Rodríguez-Arellano, Nayeli Barron-Leon, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2531-2531
Open Access | Times Cited: 12
The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges
Jiaxuan He, Fan Liu, Ting Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115807-115807
Open Access | Times Cited: 12
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Age-related p53 SUMOylation accelerates senescence and tau pathology in Alzheimer’s disease
Lu Wan, Fumin Yang, Anqi Yin, et al.
Cell Death and Differentiation (2025)
Closed Access
GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression
Arcot Rekha, Muhammad Afzal, M. Arockia Babu, et al.
Molecular and Cellular Neuroscience (2025), pp. 104005-104005
Closed Access
Exploring Stressors: Impact on Cellular Organelles and Implications for Cellular Functions
Zoofa Zayani, Arash Matinahmadi, Alireza Tavakolpournegari, et al.
Stresses (2025) Vol. 5, Iss. 2, pp. 26-26
Open Access
Molecular interplay between phytoconstituents of Ficus Racemosa and neurodegenerative diseases
Anu Rani, Zia Ul Sabah, Fauzia Tabassum, et al.
European Journal of Neuroscience (2024) Vol. 59, Iss. 7, pp. 1833-1847
Closed Access | Times Cited: 3
Anatomical, Physiological, and Pathological Changes in Different Parts of the Brain in Alzheimer's Disease
Sadegh Shirian, Narges Tahmasebian, Behnam Bakhtiari Moghadm, et al.
The Neuroscience Journal of Shefaye Khatam (2024) Vol. 12, Iss. 3, pp. 103-116
Open Access | Times Cited: 3
Minocycline effects on memory and learning impairment in the beta-amyloid-induced Alzheimer’s disease model in male rats using behavioral, biochemical, and histological methods
Zahra Gholami Mahmoudian, Ali Ghanbari, Iraj Rashidi, et al.
European Journal of Pharmacology (2023) Vol. 953, pp. 175784-175784
Closed Access | Times Cited: 8
Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer’s Disease (AD) and Prion Disease (PrD)
Walter J. Lukiw
Biomolecules (2022) Vol. 12, Iss. 2, pp. 166-166
Open Access | Times Cited: 13
Emerging Evidence of Golgi Stress Signaling for Neuropathies
Remina Shirai, Junji Yamauchi
Neurology International (2024) Vol. 16, Iss. 2, pp. 334-348
Open Access | Times Cited: 2
Distinct roles of telomerase activity in age-related chronic diseases: An update literature review
Xiaodan Wang, Hao Deng, Jingyi Lin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115553-115553
Open Access | Times Cited: 6
New Frontiers on ER Stress Modulation: Are TRP Channels the Leading Actors?
Vincenzo Vestuto, Veronica Di Sarno, Simona Musella, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 185-185
Open Access | Times Cited: 10
Recent developments in the role of DNA damage response and understanding its implications for new therapeutic approaches in Alzheimer's disease
Rajesh Ranganathan, G.V. Sapozhnikov, Ni Wang, et al.
Translational Medicine of Aging (2023) Vol. 7, pp. 52-65
Open Access | Times Cited: 4
Role of PIM Kinase Inhibitor in the Treatment of Alzheimer’s Disease
Shreyasi Meur, Swarupananda Mukherjee, Souvik Roy, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10941-10955
Closed Access | Times Cited: 1
Anthocyanin-Rich Fraction of Black Rice Bran Extract Protects against Amyloid β-Induced Oxidative Stress, Endoplasmic Reticulum Stress, and Neuronal Apoptosis in SK-N-SH Cells
Sivanan Sivasinprasasn, Jiraporn Tocharus, Sugunya Mahatheeranont, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1039-1039
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top